SCREENING AFTER STROKE - ATRIAL FIBRILLATION

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorVestre Viken Hospital Trust

About this trial

As much as 20-30% of all strokes are attributed to atrial fibrillation (AF), making the detection of AF highly important, as AF-related strokes are largely preventable with optimal treatment. Therefore, most guidelines recommend screening patients for AF after a stroke, although the optimal timing and choice of monitoring device for screening remain undefined. Our aim is to investigate whether AF screening as early as possible after stroke symptom onset provides a higher detection rate compared to screening after discharge. Additionally, we aim to determine if a 3-lead ECG device provides a higher detection rate compared to a 1-lead patch recorder.

Eligibility criteria

Qualifiers

18 years or older

Ischemic stroke

Without known AF or those with previously diagnosed paroxysmal AF exhibiting sinus rhythm upon admission

Disqualifiers

AF at hosptial admission

Unable or unwilling to provide informed consent

A life expectancy of less than one year

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

410 Participants
are grouped into 1 trial group

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Vestre Viken Hospital trust, Baerum HospitalRecruiting1346, Sogneprest Munthe-kaas Vei 100, GjettumNorwayNorway

Sponsors and collaborators